This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Endo Health Solutions Inc (ENDP): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Endo Health Solutions ( ENDP) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 1.1%. By the end of trading, Endo Health Solutions fell $1.04 (-2.2%) to $45.54 on heavy volume. Throughout the day, 3,756,776 shares of Endo Health Solutions exchanged hands as compared to its average daily volume of 1,634,900 shares. The stock ranged in price between $43.82-$46.90 after having opened the day at $46.42 as compared to the previous trading day's close of $46.58. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 32.1%, Lannett Incorporated ( LCI), down 13.4%, Zalicus ( ZLCS), down 11.3% and Neostem ( NBS), down 9.6%.

Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. Endo Health Solutions has a market cap of $5.2 billion and is part of the drugs industry. Shares are up 73.1% year to date as of the close of trading on Thursday. Currently there are 8 analysts that rate Endo Health Solutions a buy, 7 analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Endo Health Solutions as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.

On the positive front, GW Pharmaceuticals PLC ADR ( GWPH), up 175.1%, Discovery Laboratories ( DSCO), up 37.1%, Pro-Dex ( PDEX), up 20.1% and InspireMD ( NSPR), up 18.8% , were all gainers within the health care sector with Alexion Pharmaceuticals ( ALXN) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Submit an article to us!

Markets

DOW 17,949.59 -85.34 -0.47%
S&P 500 2,097.29 -3.11 -0.15%
NASDAQ 5,014.1020 +19.50 0.39%

Partners Compare Online Brokers

Top Rated Stocks Top Rated Funds Top Rated ETFs